Your trusted source for investing success
Originally from Mexico, Bryan moved to Vancouver and obtained a diploma in journalism from Langara College. He covers Life Science for Investing News Network. You can usually find him watching basketball or trying to finish news magazines.
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
The Investing News Network (INN) takes a closer look at the top biotech companies listed on the NASDAQ so far this year, with a market cap between 50 and 500 million.
Hydropothecary announced its processed medical marijuana products have been granted kosher certification by the Ottawa Vaad HaKashrut, a not-for-profit Kashrut certification agency.
Cannabis Wheaton Income announced a private placement offering for gross proceeds of up to $35 million.
Revive Therapeutics announced it entered into a license agreement with South Carolina Research Foundation.
Medovex announced it launched its DenerveX System Device in Spain with distributor Prim SA.
Rennova Health announces the Big South Fork Medical Center’s Emergency Room has received 1,005 visits in its first month of operation and admitted 45 patients for overnight stays.
ALR Technologies announced the US Food and Drug Administration granted clearance for their innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system.
Medigus announced its financial results for the second quarter of 2017.
Theralase Technologies shared new results from its patented and lead anti-cancer drug TLD-1433, in fighting a human pharyngeal carcinoma cell line.
The world’s pharmaceutical industry is dominated by the American and European markets. According to Forbes top companies of 2017, the 10 biggest drug companies are all located in these two regions.
Nabriva Therapeutics plc saw its stock get a major boost on Monday morning after the company announced top-line results from their trial of a pneumonia drug.
Liberty Health Sciences announced it secured locations for two medical cannabis dispensaries that are scheduled to open later this year.
Oncolytics Biotech shared the results from a positive End-of-Phase 2 meeting with the FDA for REOLYSIN in combination with paclitaxel.
ImmunoPrecise announced it was awarded the first commercial humanizing antibody project from an undisclosed biotech company.
Theratechnologies announced the presentation of abstract on safety data from Ibalizumab at an upcoming conference.
Cannabis Wheaton Income announced the launch of “Wheaton Licensing,” an accelerator platform to support entrepreneurs on all the stages of an application process to gain an LP status in Canada.
Tetra Bio-Pharma announces that it will be filing a clinical trial application in the coming weeks to therapeutic products directorate to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients.
GeoVax Labs announced it is providing an updated presentation of results from studies of GeoVax’s NS-1 based Zika vaccine during the Vaccine Congress conference.
Theralase Technologies announced it demonstrated 24 months long-term stability of its lead anti-cancer Photo Dynamic Compounds TLD-1433.
Send this to a friend
